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Background: Human metapneumovirus (HMPV) is now a major cause of lower respiratory infection in children.
Although primary isolation of HMPV has been achieved in several different cell lines, the low level of virus
replication and the subsequent recovery of low levels of infectious HMPV have hampered biochemical studies on
the virus. These experimental methodologies usually require higher levels of biological material that can be
achieved following HMPV infection. In this study we demonstrate that expression of the HMPV F, G and M proteins
in mammalian cells leads to HMPV virus-like particles (VLP) formation. This experimental strategy will serve as a
model system to allow the process of HMPV virus assembly to be examined.
Methods: The HMPV F, G and M proteins were expressed in mammalian cell lines. Protein cross-linking studies,
sucrose gradient centrifugation and in situ imaging was used to examine interactions between the virus proteins.
VLP formation was examined using sucrose density gradient centrifugation and electron microscopy analysis.
Results: Analysis of cells co-expressing the F, G and M proteins demonstrated that these proteins interacted.
Furthermore, in cells co-expression the three HMPV proteins the formation VLPs was observed. Image analysis
revealed the VLPs had a similar morphology to the filamentous virus morphology that we observed on
HMPV-infected cells. The capacity of each protein to initiate VLP formation was examined using a VLP formation
assay. Individual expression of each virus protein showed that the G protein was able to form VLPs in the absence
of the other virus proteins. Furthermore, co-expression of the G protein with either the M or F proteins facilitated
their incorporation into the VLP fraction.
Conclusion: Co-expression of the F, G and M proteins leads to the formation of VLPs, and that incorporation of the
F and M proteins into VLPs is facilitated by their interaction with the G protein. Our data suggests that the G
protein plays a central role in VLP formation, and further suggests that the G protein may also play a role in the
recruitment of the F and M proteins to sites of virus particle formation during HMPV infection.
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Human metapneumovirus (HMPV) is a new member of
Paramyxoviridae that was first identified in children with
respiratory diseases in Netherlands [1]. The clinical symp-
toms that are caused by HMPV infections in children are
similar to those observed with respiratory syncytial virus
(RSV) infection; ranging from mild symptoms to pneumo-
nia. HMPV is now a globally recognised cause of lower re-
spiratory infection in children [2,3]). Genetic analysis
identified two major genogroups A and B [4-6]. HMPV
expresses two major integral membrane proteins that play
a role in virus entry. The attachment (G) protein plays a
role in virus attachment and is expressed as a single poly-
peptide chain, which subsequently undergoes extensive N-
and O-linked glycosylation [7]. The fusion (F) protein
mediates fusion of the virus and host-cell membranes, and
is initially synthesised as a single polypeptide chain (F0)
that undergoes proteolytic cleavage to generate the mature
and active form of the protein, consisting of F1 and F2
protein subunits [8]. The virus also expresses a third
membrane-associated protein called the matrix (M) pro-
tein, which is analogous to the M protein of RSV and is a
major determinant of virus morphology [9].
Primary isolation of HMPV has been achieved in sev-
eral different cell lines [4,10,11], however tissue culture
adapted isolates can require up to 21 days incubation be-
fore cytopathic effects are visualised [7,11-13]. This low
level of virus replication and the subsequent recovery of
low levels of infectious HMPV in standard cell culture
have hampered biochemical studies on the virus. These
experimental methodologies usually require higher levels
of biological material than can be achieved following
HMPV infection.
Virus-like particle (VLP) formation following the co-
expression of specific virus structural proteins has been
demonstrated in several paramyxoviruses [14-18]. These
studies have allowed the identification of essential virus
proteins that are required for virus particle assembly. Al-
though a central role for the M protein in VLP formation
has been reported for human parainfluenza type 1 virus
[14] and Newcastle disease virus [16], the expression of
the M protein alone was insufficient for VLP production
in simian virus type 5 [15] and avian pneumovirus type C
[18]. The use of recombinant HMPV protein expression
to drive the formation of similar HMPV VLPs can poten-
tially overcome the problems associated with the poor cul-
tivation of HMPV in tissue culture. In addition, by direct
cloning of the virus genes from clinical material the ex-
pression of gene sequences that have not been subjected
to extensive tissue culture adaptation can be examined.
This therefore affords a relatively simple experimental sys-
tem with which to examine HMPV morphogenesis. In this
study we have examined the capacity of the HMPV F, G
and M proteins to form VLPs in mammalian cells, and tofurther examine the minimal virus protein requirements
that lead to VLP formation.
Results and discussion
Expression of the HMPV F, M and G proteins in
mammalian cells
The HMPV F and G genes were cloned directly from
HMPV strain SIN06-NTU271 and the M gene from
SIN05-NTU84 [19] without prior passage of the virus in
tissue culture. A cmyc or FLAG tag epitope was placed on
the C-terminus of the F and G proteins respectively to gen-
erate pCAGGS/F-cmyc and pCAGGS/G-FLAG respect-
ively. The M gene was cloned without an epitope tag to
generate pCAGGS/M. The HMPV strain SIN06-NTU271
and SIN05-NTU84 were identified on the basis of sequence
analysis as being of the A subtype. 293T cells transfected
with either pCAGGS, pCAGGS/F and pCAGGS/G were
surface-biotinylated and immunoprecipitated using either
anti-cmyc or anti-FLAG antibodies (Figure 1A). The F pro-
tein migrated as a 65 kDa protein species (F65), which is
the expected size for the uncleaved HMPV F protein
[20,21]. An oligomeric F protein species was also detected
(Figure 1B, highlighted by F145) which has also been
reported previously [8,20]. The glycans attached to the F
protein were resistant to Endo-H-treatment, but PNGaseF-
treatment resulted in the formation of a 58 kDa protein
species (F58), the expected size for the deglycosylated F
protein. TPCK-trypsin treatment of the recombinant F pro-
tein yielded the presence of a protein species corresponding
in size to the F1 protein subunit (Figure 1B), in a similar
manner to that described previously [8]. Collectively these
data are consistent with the authentic expression of the
F protein.
In pCAGGS/G-FLAG transfected cells the G protein
migrated as two relatively broad Endo-H-resistant pro-
tein bands of approximately 60 kDa (G60) and 120 kDa
(G120) (Figure 1A). The size of G60 was consistent with
monomeric G protein, while the GA120 kDa protein
species was consistent with an oligomeric form of G
protein. Several studies have demonstrated the propen-
sity of the HMPV G protein to form oligomers when
analysed by immunoblotting. Both G60 and G120 were
Endo-H resistant, however following PNGaseF treatment
the G protein was reduced to a faint protein smear. This
indicated removal of the N-linked glycans, and the re-
sidual protein smear was presumably due to heterogen-
eity of the remaining attached O-linked glycans [7]. The
glycosylation analysis was consistent with the presence
of mature forms of the surface-expressed F and G pro-
teins. The presence of unusually high levels G protein
oligomers in SDS PAGE analysis has been reported pre-
viously in avian metapneumovirus [22,23]. Due to its lo-
cation beneath the plasma membrane, as expected we
failed to detect the presence of biotinylated M protein.
Figure 1 Construction and surface expression of the F and G gene of HMPV isolate SIN06-NTU271. (A) pCAGGS/F-cmyc and pCAGGS/G-
FLAG were surface-biotinylated and examined by immunoprecipitation with either anti-cmyc or anti-FLAG respectively. Each surface-labelled
protein was treated with PNGasF (P), EndoH (E) or non-treated (N). Mock transfected pCAGGS (pc) vector was used to determine specificity of the
two antibodies. (B) pCAGGS/F-cmyc transfected 293T cells were either non-treated or treated with 0.5 μg/ml TPCK-trypsin for 1 hr at 37°C. The
cells were surface-biotinylated and immunoprecipitated (IP) using anti-cmyc (C) Cells transfected with pCAGGS/M and immunoblotted using
anti-M. (D and E) Cells singly transfected with pCAGGS/F-cmyc (F), pCAGGS/G-FLAG (G) or pCAGGS (Mock) transfected 293T cells were
immunoprecipitated (IP) with either anti-cmyc (cmyc) or anti-FLAG (FLAG) antibodies and Immunoblotted (IB) with (D) anti-cmyc or (E) anti-FLAG.
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transfected cells with MAbM3F8 (anti-M) revealed the
presence of a 28 kDa protein, the expected size of the
HMPV M protein (Figure 1C).
Lysates prepared from pCAGGS, pCAGGS/G-FLAG
or pCAGGS/F-cmyc transfected cells were immu-
noprecipitated using either anti-cmyc or anti-FLAG and
the immunoprecipitates then immunoblotted with either
anti-cmyc (Figure 1D) or anti-FLAG (Figure 1E). Only
pCAGGS/F-cmyc transfected cells immunoprecipitated
and immunoblotted with anti-cmyc showed the presence of
F proteins species corresponding in size to the monomeric
and oligomeric F protein (Figure 1D). In a similar analysis
G120 was only detected in pCAGGS/G-FLAG transfected
cells immunoprecipitated and then immunoblotted with
anti-FLAG (Figure 1E). This demonstrated the specificity of
the immunoprecipitation assay.
Interaction between the HMPV F and G proteins
Trypsin degradation of the G protein has been previ-
ously reported [24], and we have also noted G protein
degradation in the presence of quantities of trypsin that
are required for F protein activation (Jumat and Sugrue,
unpublished observations). Therefore, in all subsequent
studies involving G protein expression the trypsin
treatment was omitted. Cells were co-transfected with
pCAGGS/F-cmyc and pCAGGS/G-FLAG, surface-biotinylated and immunoprecipitated with anti-FLAG.
A small but discernible increase in the apparent size of
the two G protein species from G60 to G70 and from
G120 to G170 was noted (Figure 2A). Similarly, surface-
biotinylation of HMPV-infected cells and immu-
noprecipitated with anti-G showed the presence of G70
and G170 (Figure 2B). This indicated modified process-
ing of the G protein in co-transfected cells, resulting in
an apparent molecular mass that is more similar to that
observed in HMPV-infected cells. Although this sug-
gested an interaction with the F protein, immunopre-
cipitation of the co-transfected cells with anti-cmyc or
anti-FLAG and then immunoblotted using anti-cmyc
(Figure 2C) or anti-FLAG (Figure 2D) failed to demon-
strate co-precipitation of these proteins. In a similar
manner immunoprecipitation of the F protein from
HMPV-infected cells showed the presence of biotinylated
species corresponding in size to the F0 and F1 proteins
(Figure 2B). Similar ratios of the F0 and F1 proteins were
observed following trypsin treatment of the recombinant
F protein expressed in 293T cells (Figure 1B).
The F and G proteins are both integral membranes
and we hypothesized that the presence of the lipid mem-
brane may be required for stabilization of the protein
complex in situ. In this scenario the removal the lipid
membrane by detergent extraction prior to immunopre-
cipitation could lead to destabilization of the protein
Figure 2 Stabilization of the co-expressed F and G proteins by in situ protein cross-linking. (A) Cells co-transfected with pCAGGS/F-cmyc
and pCAGGS/G-FLAG, surface-biotinylated and lysates immunoprecipitated (IP) with anti-cmyc and or anti-FLAG probed with streptavidin-HRP.
(B) LLMCK2 cells were either mock-infected or infected with HMPV. At 7 days post-infection the cells were surface biotinylated and lysates were IP with
anti-G, or anti-F. The various G and F protein species are indicated. (C and D) Cells were co-transfected with pCAGGS/F-cmyc and pCAGGS/G-FLAG, IP
with anti-cmyc or anti-FLAG and immunoblotted (IB) with (C) anti-cmyc or (D) anti-FLAG. (E-H) Cells were co-transfected with pCAGGS/F-cmyc and
pCAGGS/G-FLAG and treated with increasing concentrations of DSP (0-1 mM). Detergent extracts were IP with anti-cmyc and IB with either (E) anti-
FLAG or (G) anti-cmyc, or IP with anti-FLAG and IB with (F) anti-cmyc or (H) anti-FLAG. (I and J) pCAGGS/F-cmyc and pCAGGS/G-FLAG co-transfected
cells were treated with 0.1 mM DSP and a detergent extract prepared. This was clarified and loaded onto a 5-30% sucrose gradient. The gradient was
fractionated and each fraction (I) IP with anti-cmyc and IB with anti-FLAG, or (J) IP with anti-FLAG and IB with anti-cmyc. The various monomeric and
oligomeric F and G protein species are indicated. High molecular mass F proteins are highlighted with “*”.
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nimidylpropionate] (DSP) to stabilise the protein com-
plex by in situ cross-linking prior to detergent
extraction of the virus proteins as described previously
[25,26]. Although DSP cross-linked complexes were
predicted to be beyond the resolution of SDS-PAGE
analysis (>250 kDa), following immunoprecipitation the
individual components of the stabilised protein complexes
could be released by removal of the covalent cross-links
by reductive cleavage using β-mercaptoethanol-treatment.
293T cells were co-transfected with pCAGGS/F-cmyc
and pCAGGS/G-FLAG, and the cell monolayers treated
with increasing DSP concentrations. Cell lysates were pre-
pared and immunoprecipitated with anti-cmyc, and the
presence of the G protein and F protein in the immuno-
precipitation assays detected by immunoblotting with anti-
FLAG (Figure 2E) and anti-cmyc (Figure 2G) respectively.
Immunoblotting with anti-FLAG revealed the appearance
of increasing amounts of a 170 kDa FLAG-tagged protein(the expected mass of GA170 protein) with increasing DSP
concentrations (Figure 2E). This protein was not present in
lysates prepared from non-treated cells. Probing with anti-
cmyc revealed similar levels of the monomeric (F65) and
oligomeric (F145) F protein species in both non-treated
and DSP-treated cell monolayers (Figure 2G).
Similarly lysates immunoprecipitated with anti-FLAG
and immunoblotted using anti-cmyc revealed increasing
amounts of F145 with increasing DSP concentration, to-
gether with a cmyc-tagged protein species >300 kDa
(Figure 2F) whose molecular mass was consistent with
higher oligomeric forms of the F protein. Probing with
anti-FLAG revealed monomeric (G70) and oligomeric
forms (G170) of the G protein in both non-treated and
DSP-treated monolayers (Figure 2H).
These data suggested that DSP was able to stabilise a
protein complex that formed between the F and G pro-
teins. The sedimentation characteristic of cross-linked F
and G protein complex was examined using sucrose
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pCAGGS/F-cmyc and pCAGGS/G-FLAG and treated
with 0.1 mM DSP. A detergent extract was prepared
and then applied to a continuous 5-30% (w/v) sucrose
gradient. After centrifugation the gradient was fraction-
ated, and the individual fractions immunoprecipitated
with anti-cmyc and immunoblotted with anti-FLAG
(Figure 2I) or immunoprecipitated with anti-FLAG and
immunoblotted with anti-cmyc (Figure 2J). This assay
revealed that the co-precipitating F and G proteins were
mainly located within fractions 6 to 9, consistent with
the co-migration of the DSP stabilized F and G protein
complex.
We also used fluorescence scanning confocal micros-
copy (FSCM) to examine the distribution of the G and F
proteins in pCAGGS/G-FLAG and pCAGGS/F-cmyc
(Figure 3) co-transfected cells. In pCAGGS/G-FLAG
transfected cells stained using anti-FLAG a filamentous
staining pattern was observed (Figure 3A). pCAGGS/F-
cmyc transfected cells stained using anti-cmyc exhibited
a more punctate staining pattern (Figure 3B). In cells co-
transfected with pCAGGS/G-FLAG and pCAGGS/F-
cmyc and stained with anti-cmyc and anti-FLAG a high
degree of co-localisation between the F and G proteins
within small filamentous projections was observed
(Figure 3C). This was supported by statistical analysis using
Manders and Pearsons correlation coefficients which
showed a high level of co-localisation (Figure 3D and E).
The HMPV F and G protein complex interacts with the
M protein
We next examined if the F and G proteins could interact
with the M protein. Cells were transfected with pCAGGS
(pc), pCAGGS/M (M), pCAGGS/G-FLAG and pCAGGS/
M (GM), pCAGGS/F-cmyc and pCAGGS/M (FM), or
pCAGGS/F-cmyc, pCAGGS/G-FLAG and pCAGGS/M
(FGM), and treated with 0.1 mM DSP. Detergent extracts
were immunoprecipitated with anti-M and immunoblotted
with either anti-cmyc (Figure 4A) or anti-FLAG (Figure 4B).
In both cases co-precipitation of oligomeric forms of the F
protein (Figure 4A) and G protein (Figure 4B) with the M
protein was detected. These immunoprecipitation assays
were immunoblotted using anti-M which confirmed the
presence of the M protein (Figure 4C). We failed to detect
the presence of the M protein in detergent extracts pre-
pared from pCAGGS/M transfected cells that were
immunoprecipitated with influenza virus anti-NP (i.e. a
non-specific antibody) and immunblotted with anti-M
(Figure 4C); confirming the specificity of the M protein im-
munoprecipitation. The FM- and FGM-transfected cells
were immunoprecipitated with anti-cmyc (Figure 4D), and
the GM- and FGM-transfected cells immunoprecipitated
with anti-FLAG (Figure 4E). Immunoblotting of the immu-
noprecipitation assays with anti-M revealed the presence ofthe M protein in each transfection combination. The pres-
ence of HMPV proteins in pc-transfected cells were not
detected using either antibody. Collectively, these data pro-
vided evidence of an interaction between the M protein
and the virus glycoproteins.
Co-expression of the F, G and M proteins lead to the
formation of virus-like particles
We hypothesized that the interaction of the HMPV G, F
and M proteins could lead to the formation of structures
that resembled HMPV particles. These structures would
be expected to be cell membrane-bound, and once de-
tached from the cell, they would be expected to have a
corresponding buoyant density that could be assessed
using density gradient centrifugation. The isolation of
HMPV VLPs was achieved based on a modified method
for the purification of the related RSV [27]. Cells were
transfected with pCAGGS (mock-transfected) or co-
transfected with pCAGGS/F-cmyc, pCAGGS/G-FLAG
and pCAGGS/M (FGM-transfected) and at 48 h post-
transfection the cells were harvested and processed for
VLP isolation as described in methods. The clarified cell
preparations were loaded onto 10% w/v sucrose cush-
ions, and after centrifugation the resulting pellet subse-
quently resuspended and loaded onto a discontinuous
step sucrose gradient consisting of 20%, 50% and 60%
sucrose (w/v) concentrations. After centrifugation the
material at the 0-20% (w/v), 20-50% (w/v) and 50-60% (w/v)
sucrose interfaces (Additional file 1: Figure S1) was
harvested and examined by immunoblotting using anti-
cmyc (Figure 5A), anti-FLAG (Figure 5B) and anti-M
(Figure 5C). All three HMPV proteins were found to be
present at the 20-50% sucrose density interface in FGM-
transfected cells, while no HMPV proteins were detected
in the discontinuous step sucrose gradient prepared using
the mock-transfected cells (Figure 5D, E, F).
In a similar analysis the resuspended pellet recovered
from the 10% sucrose cushion was applied to a continu-
ous 10% to 60%(w/v) sucrose gradient. After centrifuga-
tion the gradient was fractionated, and the individual
fractions proteins examined by immunoblotting using
anti-cmyc (Figure 6A), anti-FLAG (Figure 6B) and anti-
M (Figure 6C). The F and G proteins were primarily
detected in fractions 5 to 7, and this co-migration was
consistent with the identification of the protein complex
identified above. We noted that while the M protein
appeared to co-migrate with the F and G proteins in the
continuous gradient, the M protein peak fraction
exhibited a slight shift (by 1 fraction), suggesting that
the M protein may be associated with more than one
type of membrane-bound buoyant particle.
Analysis of mock-transfected and FGM-transfected
cells was performed by scanning electron microscopy
(SEM). Cells were imaged using conventional SEM and
Figure 3 (See legend on next page.)
Loo et al. Virology Journal 2013, 10:294 Page 6 of 13
http://www.virologyj.com/content/10/1/294
(See figure on previous page.)
Figure 3 HEp-2 cells co-expressing F and G proteins showing co-localisation of F and G proteins. Cells expressing either (A) the G protein
or (B) the F protein were stained using anti-FLAG and anti-cmyc respectively and imaged using confocal microscopy at an optical plane
corresponding to the cell periphery and cell top. (C) Cells co-expressing the F and G proteins were stained using anti-FLAG and anti-cmyc and
imaged using confocal microscopy at an optical plane corresponding to the cell top and cell periphery. (D) Co-localisation was calculated using
regions (white circles) within the co-transfected cells. WCC(1)-weighted co-localisation coefficient (green channel), WCC(2)-weighted co-localisation
coefficient (red channel), Mand- Manders overlap coefficient, R Pearson’s correlation coefficients. (E) An example of the scatter-plot region from one of
these circles is shown. The x-axis (1) denotes green pixel distribution, the y-axis (2) denotes red pixel distribution and region 3 denotes the yellow pixel
combination (co-localising pixels).
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showed that while mock-transfected cells exhibited a
relatively smooth surface morphology at this magnifica-
tion, FGM-transfected cells showed an increase in a fila-
mentous morphology (Figure 7A). Mock-transfected
cells and FGM-transfected cells were examined in more
detail using field emission SEM (FESEM) as described
previously [28]. Cells were stained using anti-FLAG and
anti-mouse IgG conjugated to 10 nm colloidal gold, and
the surface morphology and distribution of gold label
(indicating G protein distribution) examined. While un-
labelled surface features corresponding to microvilli
could be detected on the surface of Mock-transfected
cells, labelled filamentous projections were detected on
the surface of FGM-transfected cells (Figure 7B and C).
This was similar in appearance to the filamentous G
protein staining pattern exhibited when HMPV-infected
cells were stained using anti-G and examined by FSCM
(Figure 7D). Collectively, the sedimentation centrifuga-
tion and imaging analysis was consistent with the forma-
tion of filamentous structures on FGM-transfected cells,
which were similar in appearance to the filamentous
structures detected on HMPV-infected cells.Figure 4 Evidence that the M protein interacts with the F and G prote
proteins (FM) or F, G and M proteins (FGM) were immunoprecipitated (IP) wit
anti-M. Cells expressing the F and M proteins (FM) or F, G and M proteins (FG
various G, F and M protein species are indicated. Cells transfected with pCAGGThe G protein facilitates VLP formation
The capacity of the individual HMPV proteins to form
VLPs was examined using the discontinuous density gradi-
ent centrifugation VLP assay described above. In pCAGGS/
G-FLAG transfected cells the G protein was detected in the
total cell extract, confirming expression (Figure 8A). In the
VLP assay immunoblotting with anti-FLAG revealed G
protein species of sizes 60 kDa (G60) and 120 kDa (G120)
exclusively in the 20-50% (w/v) sucrose interface. In con-
trast, although F protein expression was detected in
pCAGGS/F-cmyc transfected cells, the F protein was not
detected in either of the three fractions (Figure 8B)
suggesting that it was not efficiently incorporated into the
VLP fraction. Similar levels of the M protein were detected
in the 0-20% (w/v) and 20-50% (w/v) sucrose interfaces
(Figure 8C), suggesting that the M protein was associated
with membrane-bound structures with at least two different
buoyant densities.
A similar analysis was performed on FG-transfected,
GM-transfected, and FM-transfected cells. In FG-
transfected cells the presence of the F and G proteins
was detected in the cell extract confirming expression
(Figure 8D). However, in FG-transfected cells F65ins. Cells expressing the M protein (M), G and M proteins (GM), F and M
h anti-M and immunoblotted (IB) with (A) anti-cmyc, (B) anti-FLAG or (C)
M) were IP with (D) anti-cmyc or (E) anti-FLAG and IB with anti-M. The
S are indicated (pc).
Figure 5 The co-expression of the F, G and M proteins leads to
the formation of virus-like particles (VLPs). Cells were either
transfected with (A, B, C) pCAGGS/F-cmyc, pCAGGS/G-FLAG, pCAGGS/M)
or (D, E, F) pCAGGS (mock-transfected) and processed for VLPs as
described in Methods. The clarified material was applied to a
discontinuous gradient composed of 20% (w/v) sucrose, 50% (w/v)
sucrose and 60% (w/v) sucrose. The material at the (1) 0-20%, (2) 20-50%
and (3) 50-60% interfaces were harvested, together with the material at
the bottom of the centrifuge tube (4). This material was analysed by
immunoblotting (IB) with (A, D) anti-cmyc, (B, E) anti-FLAG and (C, F)
anti-M. The various G, F and M protein species are indicated.
Figure 6 Continuous sucrose gradient analysis of virus-like
particles. Cells were transfected with pCAGGS/F-cmyc, pCAGGS/G-
FLAG, and pCAGGS/M and processed as described for VLP isolation
as described in methods. The resuspended pellet from the 10%
(w/v) sucrose cushion was applied to a 10-60% (w/v) continuous
sucrose gradient. After centrifugation the gradient was fractionated,
and each fraction analysed by immunoblotting with (A) anti-cmyc,
(B) anti-FLAG and (C) anti-M. The various G, F and M protein species
are indicated, as are the peak fractions (*). 1 is the top fraction and
12 the bottom fraction.
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(w/v) sucrose interface. This indicated that co-expression
of the F and G proteins facilitated incorporation of F65
into the VLP fraction. In GM-transfected cells the pres-
ence of the M and G proteins were detected in the cell
extract confirming expression (Figure 8E). However, a sig-
nificantly higher level of M protein was detected in the
20-50% (w/v) sucrose interface together with the two G
protein species. Interestingly, although both proteins were
present within the 20-50% (w/v) sucrose interface we
noted no change in the electrophoretic migration of the G
protein. In FM-transfected cells the presence of the F and
M proteins were detected in the cell extracts (Figure 8F),
however the levels of F and M protein in the sucrose in-
terfaces were similar to those detected in cells singly ex-
pressing either the F protein (Figure 8B) or M protein
(Figure 8C).Conclusions
The HMPV F and G proteins have also been shown to
bind heparan sulphate [29] and heparin [30] respectively.
The HMPV G protein exhibits many similarities to the
corresponding RSV G protein e.g. it is heavily modified by
O-linked glycosylation and can bind glycosaminoglycans
[7,31,32], which suggests a similar role for the HMPV G
protein during HMPV infection. Evidence for the inter-
action between the RSV F and G proteins in the virus en-
velope [25,33] has provided support for a single protein
complex involving both proteins. In this present study we
have also provided evidence for the existence of a similar
protein complex involving the HMPV F and G proteins.
By analogy with RSV, we can hypothesise that such a pro-
tein complex will form during HMPV replication.
Our study indicated that co-expression of the HMPV
protein was able to form VLPs, and the imaging analysis
indicated that the recombinant HMPV particles formed
as filamentous structures in a similar manner to that in
HMPV-infected cells. Similar virus filaments are formed
during morphogenesis of the closely related RSV,
suggesting some common features in the assembly
process of these different viruses. In this regard we
Figure 7 (See legend on next page.)
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Figure 7 Visualising HMPV virus-like particles (VLPs) scanning electron microscopy (SEM). Vero cells were pCAGGS-transfected (Mock) and
co-transfected with pCAGGS/F-cmyc, pCAGGS/G-FLAG, pCAGGS/M (FGM) and viewed by (A) SEM (magnification × 5,000; bar = 20 μm), the presence
of prominent filamentous projections of the surface of FGM-transfected cells is highlighted (white arrows). (B and C) Mock-transfected and
FGM-transfected cells were stained using anti-FLAG and anti-IgG conjugated to 10nm colloidal gold and viewed under field emission SEM.
(B) (magnification × 20,000; bar = 1 μm) and (C) magnification ×100,000; bar = 100 nm). The distribution of gold particles (white spots) on the
filaments is shown (white arrows). The images are superimposed images obtained using the secondary electron scatter and backscatter electron
detectors. (D) Filamentous projections formed on HMPV-infected cells. At 7 days post-infection HMPV-infected LLCMK2 cells were stained using anti-G
and examined at a focal plane corresponding to the cell periphery and cell top. The filamentous staining pattern is indicated (white arrows).
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http://www.virologyj.com/content/10/1/294noted that the HMPV G protein facilitated VLP forma-
tion independently of other HMPV proteins. Our data
also indicated that the interaction of the G protein and
the M and F proteins facilitated the incorporation of the
latter into these structures. Although the M protein has
been proposed to play a role in RSV morphogenesis,Figure 8 The HMPV G protein facilitates virus-like particle (VLP) form
transfected with (A) pCAGGS/G-FLAG, (B) pCAGGS/F-cmyc, (C) pCAGGS/M,
pCAGGS/G-FLAG, and (F) pCAGGS/F-cmyc and pCAGGS/M. HMPV protein e
lysates by immunoblotting using the appropriate antibody (Total). The tran
methods and applied to the discontinuous gradient analysis (Gradient anal
sucrose and (3) 50-60% (w/v) sucrose interfaces was harvested and immun
molecular mass G proteins are highlighted by “*”.recent data suggests that it does not play a role in the
initiation of virus particle formation [34]. Our data sug-
gested that expression of the G protein in the absence
of other virus proteins is sufficient to form these struc-
tures, and its interaction with other virus (and possibly
other unknown cell factors) may lead to their activeation by interaction with the F and M proteins. Cells were
(D) pCAGGS/F-cmyc and pCAGGS/G-FLAG, (E) pCAGGS/M and
xpression in each transfection was confirmed by analysing the cell
sfected cells were processed for VLP formation as described in
ysis). The material at the (1) 0-20% (w/v) sucrose, (2) 20-50% (w/v)
blotted using anti-FLAG, anti-cmyc or anti-M as indicated. High
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http://www.virologyj.com/content/10/1/294recruitment into VLPs. In particular, our data suggested
the presence of the F protein in these structures is
largely dependent on its association with the G protein.
It is likely that there are significant differences in the
homeostasis in virus-infected and transfected cells which
can influence virus processes. Although the VLPs and
virus particles are similar in appearance it is also likely
that there will be subtle differences between the virus
architecture in VLPs and mature virus particles that
formed on infected cells [35]. However, given these
caveats, we noted an overall similar morphology in the
HMPV VLPs and HMPV particles. Given the technical
difficulties in growing HMPV in mammalian tissue culture
cells (in particular low passage clinical isolates), the gener-
ation of HMPV VLPs in tissue culture cells may form the
basis of an experimental system to examine aspects of the
HMPV maturation process, in particular using protein
sequences derived from non-tissue culture adapted viruses).
These VLPs may also be a potential source of particulate
virus antigen that can form the basis of a vaccine candidate,
and future studies will examine these possibilities.
Materials and methods
Cloning of the HMPV F, G and M genes from
nasopharyngeal washings
Nasopharyngeal washing were collected from children
admitted to KK Women’s and Children’s Hospital for
respiratory infection as described previously [19]. The
F, G and M genes were amplified from the HMPV A2
positive Nasopharyngeal washings (SIN06-NTU271)
using the primers F271pCAGGf F271pCAGGmycr,
G271pCAGGf G271pCAGGflagr, M84pCAGGf and
M84pCAGGr (Additional file 2: Table S1). The PCR prod-
ucts were then inserted into the vector pCAGGS [17].
Antibodies
The anti-FLAG and anti-cmyc were purchased from
Sigma Aldrich and Cell Signalling respectively. M3F8
(anti-M) was prepared from bacterially expressed HMPV
M protein. The HMPV G (AT1) and F proteins (Mab58)
were obtained from Geoff Toms [36].HMPV infection
The HMPV A2 stain NCL03-4/174 was used in the LLC-
MK2 cell line in DMEM (BSA, 0.5 μgml TPCK-trypsin) at
37°C for 7 days.Expression of F, G and M proteins in (HEK) 293T cells
Cells were transfected using Lipofectamine 2000 reagent
(Invitrogen, USA) following the manufacturer’s instruc-
tions. The media was changed after 4 hr and the cells
were incubated at 37°C for 48 hr before further analysis.Western blotting
The proteins were separated by SDS–PAGE, transferred
onto PVDF membranes (Immobilon-P, Milipore, USA) as
described previously. The tagged proteins were detected
with rabbit anti-FLAG antibodies (Sigma-Aldrich, USA),
mouse anti-cmyc antibodies (Cell Signaling Technology,
USA) or mouse anti-M antibodies (Nanyang Technological
University) as appropriate. Protein bands were visualised
using the ECL system (GE Healthcare, USA). Molecular
masses were estimated using Kaleidoscope markers
(Biorad, USA).
Immunoprecipitation
Cell extracts were prepared at 4°C using RIP buffer (1%
NP-40, 0.1% SDS, 150 mM NaCl, 1 mM EDTA, 2 mM
PMSF, 2 mM lysine, 20 mM Tris–HCl, pH7.5) and clarified
by centrifugation (13,000 g, 10 min 4°C) and immunopre-
cipitated as described previously [25] using appropriate
antibodies. The immunoprecipitation assays were separated
using SDS-PAGE.
Surface labelling
Cells were surface-labelled using EZ-Link Sulfo-NHS-LC-
LC-Biotin (Pierce Biotechnology, USA) as described previ-
ously [25]. Briefly, cell monolayers were incubated in 0.5
mg/ml solution of EZ-Link Sulfo-NHS-LC-LC-Biotin
(Pierce Biotechnology, USA) in PBS pH 8 for 1 hr at room
temperature. The lysates were immunoprecipitated with
either anti-cymc or anti-FLAG as appropriate.
Protein cross-linking
In situ cross-linking was performed using Dithiobis
[succinimidylpropionate] (DSP) (Pierce Biotechnology,
USA) as described previously [25]. Briefly, the cell mo-
nolayers were treated with between 0.0 and 1.0 mM DSP
(100 mM stock solution in DMSO) in PBS pH 8.0, and the
cells were incubated at room temperature for 1 hour. The
monolayers were then washed with PBS pH 8.0 containing
2 mM lysine prior to detergent extraction with RIP buffer.
Endoglycosidase digestion
Transfected cells were lysed at 100°C for 10 min in
denaturation buffer (0 · 5% SDS, 40 mM DTT). The sam-
ples were then made up to a final concentration of either
50 mM sodium phosphate + 1% NP-40 (pH7 5) or 50 mM
sodium citrate (pH5 5) and incubated at 37°C overnight
with 1000 U PNGase F (New England Biolabs, USA) or
1000 U Endo_H (New England Biolabs, USA) respectively.
Density gradient centrifugation analysis of crosslinked
protein complexes
All steps were performed at 4°C. Cell monolayers were
extracted using RIP buffer, and the resulting lysate clari-
fied by centrifugation (13,000 g, 10 min). The clarified
Loo et al. Virology Journal 2013, 10:294 Page 12 of 13
http://www.virologyj.com/content/10/1/294lysate was layered onto a 5–30% sucrose (w/v) gradient
prepared in TEN buffer (1 mM EDTA, 100 mM NaCl,
10 mM Tris-Cl pH 8 + 0.1% Triton X-100). The gradient
was centrifuged for 18 hr at 150,000 g and 4°C (Hitachi
CP90WX preparative ultracentrifuge; Hitachi Co Ltd,
Japan).
Isolation of VLPs
Cell suspension was subjected to freeze-thaw by ethanol-
dry ice and a 37°C water bath. After 3 rounds of freeze-
thaw, the cell suspension was clarified (2,500 g for 10 min)
and loaded onto a sucrose cushion (10% w/v sucrose in
TEN buffer), and centrifuged at 200,000 g for 1 hr at 4°C
(Hitachi CP90WX ultracentrifuge). The resulting pellet
was resuspended in 200 μl of TEN buffer and loaded onto
a discontinuous sucrose gradient (20%, 50% and 60% su-
crose (w/v) in TEN buffer). The material was harvested
from each sucrose interface was harvested for further ana-
lysis. For the continuous centrifugation analysis the su-
crose pellet harvested from the sucrose cushion was
resuspended in TEN buffer and applied to a continuous
gradient (10% to 60% sucrose (w/v) in TEN buffer) and
centrifuged at 200,000 g for 18 hr at 4°C. The gradient was
harvested by removing 1ml fractions, which were then
analysed further.
Immunofluorescence and confocal microscopy
Cells transfected overnight on 10 mm glass coverslips were
fixed with methanol:acetone (1:1) for 15 min at 4°C. The
cells were labelled using anti-cmyc, anti-FLAG or anti-M
antibodies and the appropriate secondary antibodies (con-
jugated to either FITC or Alexa Fluor 555) as described
previously [37]. The cells were visualized using a Zeiss
Axioplan 2 confocal microscope using appropriate ma-
chine settings
Scanning electron microscopy (SEM)
Cells were processed as described previously [28].
Briefly, transfected cells were fixed using 0.1% glutaral-
dehyde and labeled using anti-FLAG and anti-rabbit IgG
(1/100 dilution) conjugated with colloidal gold (10 nm)
(Sigma-Aldrich, USA) for 4 hr at room temperature. The
cells were then post-fixed in 2.5% glutaraldehyde and 1%
OsO4 prior to critical point drying. The cells were car-
bon coated and viewed using either a Jeol 5600 or a Jeol
FE-SEM7000 using appropriate machine settings.Additional files
Additional file 1: Figure S1. Discontinuous sucrose gradient
concentration of virus-like particles from 293T cells. Cells were processed
for discontinuous density gradient centrifugation as described in text.
After centrifugation the opalescent bands at each interface in the sucrose
gradient was detected using a focused light. Image of ultracentrifugetube shows the presence of opalescent bands at the (1) 0-20% (w/v)
sucrose, (2) 20-50% (w/v) sucrose and (3) 50-60% (w/v) sucrose interfaces
in the analysis from pCAGGS/F-cmyc, pCAGGS/G-FLAG, pCAGGS/M
transfected cells is shown. The opalescent band at interface is
highlighted (black arrow).
Additional file 2: Table S1. Primers used for cloning of F, G and M
genes into pCAGGS vector. The underlined bases indicate restriction
enzyme recognition sites. The bases in italics are those coding for cmyc
or FLAG tags. The GenBank/EMBL/DDBJ accession numbers for the
genome sequences of HMPV isolates SIN06-NTU271 F and G genes and
SIN05-NTU84 M gene are EF397627, JQ309677, JQ309649 respectively.
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